TRex Bio, Inc. · NASDAQ:TRXB
SV Biotech Crossover Opportunities Fund LP reported a 7.00% stake in TRex Bio, Inc. (Schedule 13D)
Event Oct 8, 2026 · Filed Oct 16, 2026
SV Biotech Crossover Opportunities Fund LP reported a 7.00% stake in TRex Bio, Inc., 1,920,667 shares, with active intent on Oct 8, 2026. Filed Oct 16, 2026 (Schedule 13D).
- Stake
- 7.00%
- Shares
- 1,920,667
- Intent
- Active
- What changed
- Crossed above 5%
- Filed together
- 2 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| SV Biotech Crossover Opportunities Fund LP | 7.00% | 1,920,667 |
| SV BCO I GP LLP | 7.00% | 1,920,667 |
Source
Download original · View original at SEC
Related
- TRex Bio, Inc.
- SV Biotech Crossover Opportunities Fund LP
- TRex Bio, Inc. shareholders
- Schedule 13D · ELI LILLY & Co · Oct 16, 2026
- Schedule 13G · Pfizer Inc · Oct 16, 2026
- Form 4 · Alexandria Venture Investments, LLC · Oct 15, 2026
- Schedule 13G · Johnson & Johnson Innovation - JJDC, Inc. · Oct 15, 2026
- Form 4 · Marcus Joel S · Oct 13, 2026